Ann: SK-II Success and Forward Planning, page-147

Thanks for your post Jase.
I would have thought that FIM pty ltd would be the home of any pfizer patch work being carried out also. Especially considering they changed the name some years ago from transdermal vaccines pty ltd to FIM.
Obviously the co would never admit to this due to confidentiality, but there has still been a deliberate addition of pfizer in our last presentation as a major partner and OBJ must have got the "all clear" to name them in the report.

The capital raising situation that has risen is pure flamboyance from obvious jawboning on here.

The GSK situation also has a lot of unanswered aspects to the current projects. I mean surely we should have heard something official from gsk oral by now about the results and analysis of the in vivo, as others have commented on, there were two other studies being carried apart from fluoride intake and even that little "verbal" snippet in a quarterly is very odd.
And then there is analgesics that has just fallen off a cliff after two back to back successful trials, then nothing.

so, we wait.